Feng Gao, MD, PhD

Feng Gao, MD, PhD

Primary Academic Title

Professor of Surgery, Division of Public Health Sciences, Washington University School of Medicine

Research Interest

Development of mathematical/statistical methodology for survival data and longitudinal data. Also, statistical design and data analysis for cancer-related studies.


  • 1990: MD, preventive medicine, Beijing Medical University
  • 1996: MPH, medical statistics, Beijing Medical University
  • 2002: MS/PhD, biostatistics, Emory University, Atlanta

Selected Research Publications

Idasanutlin and navitoclax induce synergistic apoptotic cell death in T-cell acute lymphoblastic leukemia.
  • Johansson KB, Zimmerman MS, Dmytrenko IV, Gao F , Link DC
  • Leukemia 2023
An "off-the-shelf" CD2 universal CAR-T therapy for T-cell malignancies.
  • Xiang J, Devenport JM, Carter AJ, [...] Gao F, [...] DiPersio JF
  • Leukemia 2023
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy.
  • Ferraro F, Gruszczynska A, Ruzinova MB, [...] Gao F, [...] Welch JS
  • Haematologica 2022
A long-acting interleukin-7, rhIL-7-hyFc, enhances CAR T cell expansion, persistence, and anti-tumor activity.
  • Kim MY, Jayasinghe R, Devenport JM, [...] Gao F, [...] DiPersio JF
  • Nat Commun 2022
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
  • Berrien-Elliott MM, Becker-Hapak M, Cashen AF, [...] Gao F, [...] Fehniger TA
  • Blood 2022
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies.
  • Lim KH, Opyrchal M, Acharya A, [...] Gao F, [...] Wang-Gillam A
  • Eur J Cancer 2021
Phase I Trial of N-803, an IL15 Receptor Agonist, with Rituximab in Patients with Indolent Non-Hodgkin Lymphoma.
  • Foltz JA, Hess BT, Bachanova V, [...] Gao F, [...] Fehniger TA
  • Clin Cancer Res 2021

View All Publications